Axel Hauschild (A Hauschild)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Convolutional Neural Network

Systematic Review

Top Venues

Journal of medical Internet research

Cancer immunology, immunotherapy : CII

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander C J van Akkooi, Axel Hauschild, Georgina V Long, Mario Mandala, Michal Kicinski, Anne-Sophie Govaerts, Isabelle Klauck, Monia Ouali, Paul C Lorigan, Alexander M M Eggermont
COLUMBUS-AD: phase III study of adjuvant encorafenib + binimetinib in resected stage IIB/IIC BRAF V600-mutated melanoma. Future oncology (London, England) (2023)
Peter Mohr, Emilie Scherrer, Chalid Assaf, Marc Bender, Carola Berking, Sheenu Chandwani, Thomas Kurt Eigentler, Imke Grimmelmann, Ralf Gutzmer, Sebastian Haferkamp, Jessica C Hassel, Axel Hauschild, Rudolf Herbst, Ruixuan Jiang, Katharina C Kähler, Clemens Krepler, Alexander Kreuter, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Claudia Pföhler, Anja Rudolph, Dirk Schadendorf, Maximo Schiavone, Gaston Schley, Patrick Terheyden, Selma Ugurel, Jens Ulrich, Jochen Sven Utikal, Carsten Weishaupt, Julia Welzel, Michael Weichenthal
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany. Cancers 14 (7) (2022)
R Gutzmer, H-J Schulze, Axel Hauschild, Ulrike Leiter, Friedegund Meier, S Haferkamp, C Ulrich, R U Wahl, Carola Berking, R Herbst, M Häckl, Dirk Schadendorf
Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real-world conditions in Germany - The non-interventional study NIELS. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (8) (2021)
Max Schmitt, Roman Christoph Maron, Achim Hekler, Albrecht Stenzinger, Axel Hauschild, Michael Weichenthal, Markus Tiemann, Dieter Krahl, Heinz Kutzner, Jochen Sven Utikal, Sebastian Haferkamp, Jakob Nikolas Kather, Frederick Klauschen, Eva Krieghoff-Henning, Stefan Fröhling, Christof von Kalle, Titus Josef Brinker
Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model Study. Journal of medical Internet research 23 (2) (2021)
Julia Höhn, Achim Hekler, Eva Krieghoff-Henning, Jakob Nikolas Kather, Jochen Sven Utikal, Friedegund Meier, Frank Friedrich Gellrich, Axel Hauschild, Lars Einar French, Justin Gabriel Schlager, Kamran Ghoreschi, Tabea Wilhelm, Heinz Kutzner, Markus Vincent Heppt, Sebastian Haferkamp, Wiebke Sondermann, Dirk Schadendorf, Bastian Schilling, Roman Christoph Maron, Max Schmitt, Tanja Jutzi, Stefan Fröhling, Daniel B Lipka, Titus Josef Brinker
Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review. Journal of medical Internet research 23 (7) (2021)
Roman Christoph Maron, Jochen Sven Utikal, Achim Hekler, Axel Hauschild, Elke C Sattler, Wiebke Sondermann, Sebastian Haferkamp, Bastian Schilling, Markus Vincent Heppt, Philipp Jansen, Markus Reinholz, Cindy Franklin, Laurenz Schmitt, Daniela Hartmann, Eva Krieghoff-Henning, Max Schmitt, Michael Weichenthal, Christof von Kalle, Stefan Fröhling, Titus Josef Brinker
Artificial Intelligence and Its Effect on Dermatologists' Accuracy in Dermoscopic Melanoma Image Classification: Web-Based Survey Study. Journal of medical Internet research 22 (9) (2020)
John T Lear, Axel Hauschild, Eggert Stockfleth, Nicholas Squittieri, Nicole Basset-Seguin, Reinhard Dummer
Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial. Clinical, cosmetic and investigational dermatology 13 (2020)
Benjamin Weide, Thomas Kurt Eigentler, Chiara Catania, Paolo Antonio Ascierto, Stefano Cascinu, Jürgen Christian Becker, Axel Hauschild, Antonella Romanini, Riccardo Danielli, Reinhard Dummer, Uwe Trefzer, Giuliano Elia, Dario Neri, Claus Garbe
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients. Cancer immunology, immunotherapy : CII 68 (9) (2019)